autologous bone marrow derived CD34+ HSPCs electroporated with BCL11A enhancer targeting Cas9 ribonucleoprotein: clinical trials recruiting now
Fewer than 3 recruiting trials found.
1
Recruiting trials
4
Conditions studied
1
US states with sites
1
Countries
Phase breakdown
Phase 1 1
Conditions being studied
| Condition | Trials |
|---|---|
| Beta-Thalassemia | 1 |
| Sickle Cell Anemia (HbSS, or HbSβ-thalassemia0) | 1 |
| Sickle Cell Disease | 1 |
| Transfusion Dependent Beta-Thalassaemia | 1 |
Recruiting trials involving autologous bone marrow derived CD34+ HSPCs electroporated with BCL11A enhancer targeting Cas9 ribonucleoprotein
Common questions
How many recruiting trials involve autologous bone marrow derived CD34+ HSPCs electroporated with BCL11A enhancer targeting Cas9 ribonucleoprotein?
1 recruiting trial across 4 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.